The White House Office of Management and Budget (OMB) released two memos directed to the heads of all executive branch departments and agencies establishing policies on federal AI use and purchase of AI in government.
The memos, which align with an Executive Order President Donald Trump signed in January, replace former President Joe Biden's previous guidance (M-24-10 and M-24-18) but maintain...
LAS VEGAS - At the 2025 HIMSS Global Conference & Exhibition here, Tom Leary, senior vice president and head of government relations at HIMSS, and Jonathan French, senior director of public policy and content development at HIMSS, discussed the organization's role in progressing health technology policy in government.
In their talk, "Forecasting the Global Policy Landscape in 2025," the pair...
Proposed legislation introduced in the U.S. House of Representatives will allow AI and machine learning technology to prescribe drugs approved by the FDA autonomously.
The bill, H.R.238, introduced on Jan. 7, would require amending the Federal Food, Drug, and Cosmetic Act (FFDCA) to "clarify that artificial intelligence and machine learning technologies can qualify as a practitioner eligible, to...
The European Union has released Guidelines to provide legal clarity on the prohibited uses of AI within the EU AI Act to ensure effective, consistent and uniform application and protect European citizens' rights and safety.
The EU AI Act, which outlines regulations for the development, market placement, implementation and use of artificial intelligence in the European Union, came into effect in...
On his first day in office of his second term, President Donald Trump revoked Joe Biden's 2023 executive order, which aimed to establish standards for the safe, secure and trustworthy development of AI across various sectors, including healthcare.
Among its many provisions, Biden's order directed the U.S. Department of Health and Human Services (HHS) to establish a safety program "to help ensure...
At a Boston Consulting Group (BCG) event in San Francisco during the JPM Healthcare Conference taking place this week, panelists discussed the government's role in advancing AI technology and government oversight of the technology with the changing administration.
Micky Tripathi, assistant secretary for technology policy, national coordinator for health IT and chief AI officer for the U.S....
The Food and Drug Administration (FDA) has released its perspective on regulating AI in healthcare and biomedicine, stating that oversight needs to be coordinated across all regulated industries, international organizations and the U.S. government.
The Agency says it regulates industries that distribute their products to the global market, and therefore U.S. regulatory standards must be...
The EU AI Act comes into effect today, outlining regulations for the development, market placement, implementation and use of artificial intelligence in the European Union.
The Council wrote that the Act is intended to "promote the uptake of human-centric and trustworthy artificial intelligence while ensuring a high level of protection of health, safety, [and] fundamental rights … including...
Note: Andreessen Horowitz says views expressed by its employees are their own and should not be taken as investment advice. More details at https://a16z.com/disclosures/.
As 2023 comes to a close, Jay Rughani, investment partner at Andreessen Horowitz, joined MobiHealthNews to discuss his takeaways from the year, noteworthy events, recommendations for regulators forming rules around AI in...
